Application 211680
- Type
- ANDA
- Sponsor
- CIPLA LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | EMTRICITABINE, TENOFOVIR ALAFENAMIDE | TABLET | 200MG/25MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.